Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuraminidase inhibitor].

M Kaji1

  • 1Kurume University Medical Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 28, 2001
PubMed
Summary
This summary is machine-generated.

Amantadine treats influenza A, while newer neuraminidase inhibitors like Zanamivir and Oseltamivir are effective for both influenza A and B. This review details their mechanisms, dosages, and side effects for clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retracted: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson’s Disease Patients With Vitamin D Deficiency.

Bone·2017
Same author

Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.

American journal of physiology. Endocrinology and metabolism·2013
Same author

Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

Cancer chemotherapy and pharmacology·2013
Same author

Prognostic value of urokinase-type plasminogen activators in gastric-cancer.

Oncology reports·2011
Same author

E-cadherin and c-met expression as a prognostic factor in gastric cancer.

Oncology reports·2011
Same author

Serum erbb-2 protein for the diagnosis of gastric-cancer.

International journal of oncology·2011

Area of Science:

  • Virology
  • Pharmacology

Context:

  • Amantadine is a widely used influenza A treatment in Japan.
  • Neuraminidase inhibitors, including Zanamivir and Oseltamivir, represent a newer class of anti-influenza agents.

Purpose:

  • To review the mechanisms of action, dosages, and side effects of Amantadine, Zanamivir, and Oseltamivir.
  • To provide clinicians with information for timely influenza treatment.

Summary:

  • Amantadine targets influenza A virus.
  • Zanamivir (inhaled) and Oseltamivir (oral) are effective against both influenza A and B viruses.
  • Key pharmacological details such as mechanism, dosage, and side effects are discussed for each agent.

Impact:

  • Facilitates informed clinical decisions regarding influenza antiviral therapy.

Related Experiment Videos

  • Highlights the availability and efficacy of newer antiviral options.
  • Aims to improve patient outcomes through prompt and appropriate medication.